Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_STR_SAH,Inverse variance weighted,3,0.79 [0.69-0.9],0.000566843618383307,cis
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,Inverse variance weighted,5,0.84 [0.76-0.94],0.00130736228230585,cis
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,AB1_GASTROENTERITIS_NOS,Inverse variance weighted,5,1.11 [1.04-1.19],0.00225206755832716,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,GOUT_NOS,Inverse variance weighted,5,0.79 [0.67-0.92],0.00281895186558901,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_CARDARR,Inverse variance weighted,5,0.69 [0.53-0.88],0.00354151315732414,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_STR_EXH,Inverse variance weighted,3,0.81 [0.69-0.94],0.00456617875935436,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SPONDYLOSIS,Inverse variance weighted,5,1.14 [1.04-1.25],0.00551616443616048,cis
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,AB1_INTESTINAL_INFECTIONS,Inverse variance weighted,5,1.08 [1.01-1.14],0.0157242078323128,cis
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,Inverse variance weighted,3,0.76 [0.61-0.95],0.0161345299427956,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_STEMI,Inverse variance weighted,3,0.75 [0.59-0.95],0.0164010408593657,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_HEARTFAIL,Inverse variance weighted,5,0.91 [0.85-0.99],0.0195250543974103,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SPONDYLOPATHY,Inverse variance weighted,5,1.08 [1.01-1.15],0.0198328091585252,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_K_CARDIAC,Inverse variance weighted,5,0.9 [0.82-0.98],0.0214194097316579,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUE,Inverse variance weighted,5,1.06 [1.01-1.12],0.0258820188342105,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_OTHOTH,Inverse variance weighted,5,0.67 [0.47-0.96],0.0275714450815059,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_LBBB,Inverse variance weighted,5,0.77 [0.59-0.99],0.0442327523582854,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSOPATHYOTH,Inverse variance weighted,5,1.05 [1-1.1],0.0447121860469233,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIV Diseases of the genitourinary system,N14_DIALYSIS,Inverse variance weighted,5,1.44 [1.01-2.05],0.0447966316128464,cis
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,AB1_STREPTSTAPHYCOCC_INOTHER,Inverse variance weighted,5,2.53 [1.02-6.31],0.0456881441355295,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,Inverse variance weighted,5,0.87 [0.75-1],0.0574105902845713,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_AVBLOCK,Inverse variance weighted,5,0.81 [0.65-1.01],0.0594160151156234,cis
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,Inverse variance weighted,5,0.94 [0.88-1],0.0607196488086802,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SLE,Inverse variance weighted,3,0.41 [0.16-1.06],0.0657890192621924,cis
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2OPTH,Inverse variance weighted,5,0.85 [0.71-1.01],0.0695764584002701,cis
FABP1,"Fatty acid-binding protein, liver",Chapter VI Diseases of the nervous system,G6_POLYOTHUNS,Inverse variance weighted,5,1.17 [0.99-1.39],0.0716004191817426,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_ANGINA,Inverse variance weighted,5,1.07 [0.99-1.16],0.0724305406312161,cis
FABP1,"Fatty acid-binding protein, liver",Chapter X Diseases of the respiratory system,COPD_LATER,Inverse variance weighted,5,0.9 [0.8-1.01],0.0727727661075488,cis
FABP1,"Fatty acid-binding protein, liver",Chapter X Diseases of the respiratory system,J10_ASTHMA_EXMORE,Inverse variance weighted,5,1.06 [0.99-1.12],0.0747324962218749,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_ARTOTH,Inverse variance weighted,5,1.23 [0.97-1.56],0.0846016639626883,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_CARDMYO,Inverse variance weighted,5,0.85 [0.71-1.02],0.0873780472608925,cis
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,Inverse variance weighted,5,0.95 [0.9-1.01],0.0876863972758492,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_PULMOTHHD,Inverse variance weighted,3,0.72 [0.5-1.05],0.0912478826125671,cis
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,AB1_VIRAL_OTHER_INTEST_INFECTIONS,Inverse variance weighted,5,0.89 [0.78-1.02],0.0942050210602002,cis
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,Inverse variance weighted,5,0.88 [0.75-1.02],0.0971842360427869,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_GOUT,Inverse variance weighted,5,0.9 [0.79-1.02],0.0989504275742277,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,Inverse variance weighted,5,0.95 [0.88-1.01],0.10365394959499,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_GIDISEASES,Inverse variance weighted,3,0.96 [0.92-1.01],0.112986841587644,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_UAP,Inverse variance weighted,5,1.1 [0.98-1.25],0.114048356451636,cis
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,AB1_BACT_INTEST_OTH,Inverse variance weighted,5,1.15 [0.96-1.38],0.120991653302131,cis
FABP1,"Fatty acid-binding protein, liver","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H7_CATARACTOTHER,Inverse variance weighted,5,1.07 [0.98-1.18],0.126242923716093,cis
FABP1,"Fatty acid-binding protein, liver",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_PURPURA_AND3_OTHER_HAEMORRHAGIC,Inverse variance weighted,5,0.87 [0.73-1.04],0.132721011176705,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_CHD,Inverse variance weighted,5,1.05 [0.98-1.12],0.135781244342996,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_IHD,Inverse variance weighted,5,1.05 [0.98-1.11],0.143462229628993,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSOPATHY,Inverse variance weighted,5,1.03 [0.99-1.07],0.145203521665821,cis
FABP1,"Fatty acid-binding protein, liver",Chapter X Diseases of the respiratory system,J10_LOWCHRON,Inverse variance weighted,5,1.04 [0.99-1.09],0.146519988560032,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_MI_STRICT,Inverse variance weighted,5,1.06 [0.98-1.16],0.14814038133318,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,COLITNONINFNAS,Inverse variance weighted,3,1.11 [0.96-1.27],0.148555787663802,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XII Diseases of the skin and subcutaneous tissue,L12_ULCERLOWLIMB,Inverse variance weighted,5,1.15 [0.95-1.39],0.153733132327907,cis
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,AB1_MYCOSES,Inverse variance weighted,5,0.9 [0.77-1.04],0.154268575573577,cis
FABP1,"Fatty acid-binding protein, liver",Chapter X Diseases of the respiratory system,J10_PLEURA,Inverse variance weighted,5,1.07 [0.97-1.18],0.1575551480433,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_OTHGASTR,Inverse variance weighted,5,0.91 [0.8-1.04],0.164319243331273,cis
FABP1,"Fatty acid-binding protein, liver",Chapter X Diseases of the respiratory system,J10_PNEUMONAS,Inverse variance weighted,3,0.9 [0.77-1.05],0.175187378183351,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,Inverse variance weighted,5,0.65 [0.35-1.22],0.176790211267896,cis
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,Inverse variance weighted,5,0.91 [0.79-1.05],0.180761894404599,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_PERITON,Inverse variance weighted,5,0.87 [0.71-1.07],0.182408581055853,cis
FABP1,"Fatty acid-binding protein, liver",Chapter VI Diseases of the nervous system,G6_NERPLEX,Inverse variance weighted,5,0.96 [0.91-1.02],0.184822848580283,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_NOS,Inverse variance weighted,5,1.17 [0.93-1.48],0.186116900044423,cis
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_OBESITYNAS,Inverse variance weighted,5,1.07 [0.96-1.2],0.193839115261219,cis
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,Inverse variance weighted,5,0.89 [0.74-1.06],0.196471391456313,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_CROHN,Inverse variance weighted,3,1.21 [0.91-1.61],0.198883500581867,cis
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_OBESITY,Inverse variance weighted,5,1.05 [0.97-1.14],0.210435350836867,cis
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPEROSMHNAT,Inverse variance weighted,5,1.48 [0.8-2.76],0.212434710256834,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_ALCOLIV,Inverse variance weighted,5,1.15 [0.92-1.42],0.214327276341466,cis
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,Inverse variance weighted,5,0.83 [0.62-1.12],0.216645979669688,cis
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,Inverse variance weighted,5,1.7 [0.72-3.98],0.222735058418909,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_DISLIVOTH,Inverse variance weighted,5,0.91 [0.78-1.07],0.242461953366459,cis
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOKALAEMIA,Inverse variance weighted,5,1.12 [0.92-1.37],0.244680994926989,cis
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACT_INOTHER,Inverse variance weighted,5,0.66 [0.33-1.33],0.248964995730188,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_CORATHER,Inverse variance weighted,5,1.04 [0.97-1.13],0.255913307332736,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_GIBLEEDING,Inverse variance weighted,3,0.94 [0.84-1.05],0.256910558118645,cis
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,Inverse variance weighted,5,0.86 [0.67-1.12],0.258081708915334,cis
FABP1,"Fatty acid-binding protein, liver",Chapter V Mental and behavioural disorders,SMOKING_DEPEND,Inverse variance weighted,5,1.15 [0.9-1.46],0.265257936986331,cis
FABP1,"Fatty acid-binding protein, liver","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_MACULOPATHY_EXMORE,Inverse variance weighted,5,1.11 [0.92-1.34],0.280953410367858,cis
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_FUNGAL_IMPL,Inverse variance weighted,3,0.87 [0.67-1.12],0.28770565425966,cis
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACTERIAL,Inverse variance weighted,5,1.03 [0.97-1.09],0.287773792101002,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_OTHINFLIV,Inverse variance weighted,5,1.15 [0.88-1.5],0.302651448215627,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIV Diseases of the genitourinary system,N14_ACUTERENFAIL,Inverse variance weighted,5,1.09 [0.92-1.29],0.306199416913243,cis
FABP1,"Fatty acid-binding protein, liver","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_BCKGRND_RETINA,Inverse variance weighted,3,0.86 [0.64-1.15],0.310559040655128,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUEOTH,Inverse variance weighted,5,1.05 [0.96-1.14],0.313517123343586,cis
FABP1,"Fatty acid-binding protein, liver",Chapter X Diseases of the respiratory system,J10_PULMOEDEMA,Inverse variance weighted,5,1.36 [0.74-2.52],0.323976007790858,cis
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,AB1_INFECT_PARASIT,Inverse variance weighted,3,0.97 [0.91-1.03],0.326237716050465,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_PERITONITIS,Inverse variance weighted,5,0.86 [0.64-1.16],0.32689339349155,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,Inverse variance weighted,5,0.83 [0.57-1.21],0.330690017157307,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,Inverse variance weighted,5,0.84 [0.58-1.21],0.343204271194439,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_ENERCOLNONINF,Inverse variance weighted,5,0.94 [0.82-1.07],0.348620727246539,cis
FABP1,"Fatty acid-binding protein, liver",Chapter V Mental and behavioural disorders,F5_DEPRESSIO,Inverse variance weighted,5,1.03 [0.97-1.1],0.350496353056733,cis
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,Inverse variance weighted,3,0.94 [0.84-1.07],0.359205783651026,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOPOROSIS,Inverse variance weighted,5,1.06 [0.93-1.22],0.36190102979127,cis
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,Inverse variance weighted,5,0.96 [0.88-1.05],0.372395836720565,cis
FABP1,"Fatty acid-binding protein, liver",Chapter X Diseases of the respiratory system,J10_EMPHYSEMA,Inverse variance weighted,5,0.89 [0.68-1.15],0.376524804230199,cis
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,Inverse variance weighted,5,1.28 [0.74-2.2],0.376775239701067,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_OTHDISDIG,Inverse variance weighted,5,1.05 [0.94-1.17],0.382773500064756,cis
FABP1,"Fatty acid-binding protein, liver",Chapter V Mental and behavioural disorders,KRA_PSY_MOOD_EXMORE,Inverse variance weighted,3,0.96 [0.88-1.05],0.383472526606369,cis
FABP1,"Fatty acid-binding protein, liver",Chapter X Diseases of the respiratory system,J10_ACUTELOWERNAS,Inverse variance weighted,5,1.08 [0.91-1.27],0.386733772454044,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_NSTEMI,Inverse variance weighted,3,0.9 [0.7-1.15],0.386810408746738,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_OTHENTERCOL,Inverse variance weighted,5,0.93 [0.79-1.09],0.387259901076208,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,Inverse variance weighted,5,1.09 [0.9-1.32],0.389771899721239,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_COELIAC,Inverse variance weighted,5,1.09 [0.9-1.31],0.392616769549742,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIV Diseases of the genitourinary system,N14_URINOTH,Inverse variance weighted,5,0.98 [0.92-1.03],0.396370515108547,cis
FABP1,"Fatty acid-binding protein, liver",Chapter X Diseases of the respiratory system,J10_LOWERINF,Inverse variance weighted,5,1.05 [0.94-1.17],0.41451442849054,cis
FABP1,"Fatty acid-binding protein, liver",Chapter X Diseases of the respiratory system,J10_INTERSTITIUM,Inverse variance weighted,3,0.91 [0.74-1.13],0.414675770073269,cis
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_IMPLICIT,Inverse variance weighted,3,0.97 [0.89-1.05],0.422212525663423,cis
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_BACT_IMPL,Inverse variance weighted,3,0.95 [0.85-1.07],0.422482303397516,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_MALABSORB,Inverse variance weighted,5,0.88 [0.64-1.21],0.424376774667401,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_OTHDIG,Inverse variance weighted,5,1.04 [0.95-1.14],0.427687617228826,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XII Diseases of the skin and subcutaneous tissue,L12_CELLULITIS,Inverse variance weighted,5,1.06 [0.92-1.21],0.434699849436371,cis
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,IBD_BACT_INTEST_INFECTIONS,Inverse variance weighted,3,0.91 [0.73-1.14],0.436612168988511,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Inverse variance weighted,5,0.94 [0.82-1.09],0.441230296500486,cis
FABP1,"Fatty acid-binding protein, liver",Chapter VI Diseases of the nervous system,G6_NEURO,Inverse variance weighted,3,0.97 [0.9-1.05],0.449734246800691,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_SEQULAE,Inverse variance weighted,5,0.95 [0.85-1.08],0.454548923977549,cis
FABP1,"Fatty acid-binding protein, liver",Chapter X Diseases of the respiratory system,COPD_EARLY,Inverse variance weighted,5,0.95 [0.83-1.09],0.455013175986144,cis
FABP1,"Fatty acid-binding protein, liver",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIANAS,Inverse variance weighted,5,0.96 [0.87-1.06],0.465441859997248,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XII Diseases of the skin and subcutaneous tissue,L12_SKIN_SUBCUTAN,Inverse variance weighted,3,0.97 [0.89-1.06],0.469489707755932,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHRITISNAS,Inverse variance weighted,3,0.97 [0.88-1.06],0.470452470631782,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_RBBB,Inverse variance weighted,5,1.14 [0.79-1.65],0.472565714748544,cis
FABP1,"Fatty acid-binding protein, liver",Chapter VI Diseases of the nervous system,G6_CPETAL,Inverse variance weighted,5,0.93 [0.77-1.13],0.476302545753,cis
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_EXPLICIT,Inverse variance weighted,3,0.96 [0.85-1.08],0.476988559505354,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,NAFLD,Inverse variance weighted,5,1.09 [0.86-1.38],0.477466940730932,cis
FABP1,"Fatty acid-binding protein, liver",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_THROMBOCYTOPENIANAS,Inverse variance weighted,5,0.87 [0.59-1.28],0.479311802502672,cis
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,Inverse variance weighted,3,0.91 [0.7-1.19],0.479895772891382,cis
FABP1,"Fatty acid-binding protein, liver",Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,Inverse variance weighted,5,0.97 [0.88-1.06],0.481045735062619,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS_OTH,Inverse variance weighted,5,1.04 [0.93-1.16],0.487041765699362,cis
FABP1,"Fatty acid-binding protein, liver",Chapter V Mental and behavioural disorders,F5_ALCOHOL_DEPENDENCE,Inverse variance weighted,5,0.94 [0.78-1.13],0.509753112501475,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_HYPTENSPUL,Inverse variance weighted,5,1.27 [0.61-2.65],0.519790058482449,cis
FABP1,"Fatty acid-binding protein, liver",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_BLOOD_IMMUN,Inverse variance weighted,3,1.02 [0.95-1.1],0.52361678855473,cis
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,Inverse variance weighted,5,1.34 [0.54-3.31],0.525666851862706,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XII Diseases of the skin and subcutaneous tissue,L12_INFECT_SKIN,Inverse variance weighted,5,1.03 [0.95-1.11],0.526443597491694,cis
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_ACIDOSIS,Inverse variance weighted,5,1.2 [0.68-2.15],0.526806829922572,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_HYPOTE,Inverse variance weighted,5,0.95 [0.8-1.12],0.527262370970281,cis
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,AB1_OTHER_SEPSIS,Inverse variance weighted,5,0.97 [0.87-1.07],0.530273886993865,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_OTHILLHEART,Inverse variance weighted,5,0.89 [0.62-1.28],0.539456927309745,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_OTHPER,Inverse variance weighted,5,1.08 [0.85-1.37],0.539636620846245,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS,Inverse variance weighted,5,1.02 [0.97-1.07],0.547085433302195,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_OTHFUNC,Inverse variance weighted,5,1.03 [0.94-1.13],0.550917768242651,cis
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,Inverse variance weighted,5,0.98 [0.93-1.04],0.552501689113229,cis
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,Inverse variance weighted,5,0.93 [0.72-1.19],0.553501234018229,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_PAD,Inverse variance weighted,3,1.05 [0.88-1.26],0.561344289730994,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XII Diseases of the skin and subcutaneous tissue,L12_DECUBITANSULCERANDPRESSURE,Inverse variance weighted,5,0.85 [0.49-1.48],0.567787615102898,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_OESSTODUO,Inverse variance weighted,5,0.99 [0.94-1.04],0.600125886884907,cis
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_CONDITION,Inverse variance weighted,3,0.98 [0.9-1.06],0.603954489629701,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_INTESTOTH,Inverse variance weighted,5,0.99 [0.94-1.04],0.605304130486152,cis
FABP1,"Fatty acid-binding protein, liver",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIAINCHRONICDISEASE,Inverse variance weighted,5,0.86 [0.47-1.57],0.622465280502705,cis
FABP1,"Fatty acid-binding protein, liver",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_IRONDEF_NAS,Inverse variance weighted,5,0.97 [0.86-1.09],0.627040629072437,cis
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,AB1_BACTINF_NOS,Inverse variance weighted,5,1.02 [0.94-1.11],0.629757496482507,cis
FABP1,"Fatty acid-binding protein, liver",Chapter VI Diseases of the nervous system,G6_HEMIPLE,Inverse variance weighted,5,0.93 [0.7-1.24],0.630664065207094,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIV Diseases of the genitourinary system,N14_CHRONEPHROPATH,Inverse variance weighted,5,0.92 [0.66-1.29],0.632072994188509,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_PAROXTAC,Inverse variance weighted,5,1.03 [0.91-1.16],0.634977706158548,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_HEPFAIL,Inverse variance weighted,5,1.13 [0.67-1.9],0.640632353347806,cis
FABP1,"Fatty acid-binding protein, liver",Chapter V Mental and behavioural disorders,AUD,Inverse variance weighted,5,0.97 [0.87-1.09],0.641957322462631,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_GASTRODUOULC,Inverse variance weighted,5,0.97 [0.84-1.11],0.643861418070851,cis
FABP1,"Fatty acid-binding protein, liver",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERANAEMIA,Inverse variance weighted,3,1.02 [0.93-1.12],0.657013551832513,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_MUSCULOSKELETAL,Inverse variance weighted,3,1.01 [0.96-1.06],0.659051126428721,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_RHEUMA,Inverse variance weighted,5,1.03 [0.9-1.18],0.670599127714767,cis
FABP1,"Fatty acid-binding protein, liver",Chapter X Diseases of the respiratory system,COPD_HOSPITAL_MAIN,Inverse variance weighted,3,0.98 [0.88-1.09],0.677328253343612,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,CHIRHEP_NAS,Inverse variance weighted,5,1.07 [0.77-1.5],0.683398357402516,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_LIVER,Inverse variance weighted,5,1.02 [0.91-1.15],0.685624480397407,cis
FABP1,"Fatty acid-binding protein, liver",Chapter V Mental and behavioural disorders,F5_DEPRESSION_DYSTHYMIA,Inverse variance weighted,5,0.99 [0.93-1.05],0.689168387124422,cis
FABP1,"Fatty acid-binding protein, liver",Chapter VI Diseases of the nervous system,FALLS,Inverse variance weighted,5,1.01 [0.96-1.07],0.693468467577763,cis
FABP1,"Fatty acid-binding protein, liver","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H7_CHOROIDRETINA,Inverse variance weighted,5,0.98 [0.87-1.1],0.698728562489233,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_VARICVEOES,Inverse variance weighted,5,1.07 [0.75-1.53],0.698952997006234,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_ILEUS,Inverse variance weighted,5,0.96 [0.77-1.2],0.708107460336845,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_HYPTENSPOR,Inverse variance weighted,3,0.93 [0.62-1.38],0.709401113962632,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,Inverse variance weighted,5,0.93 [0.63-1.38],0.711979191010433,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,JOINTPAIN,Inverse variance weighted,5,0.99 [0.92-1.06],0.71724476006094,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,Inverse variance weighted,5,0.98 [0.89-1.09],0.7173612058918,cis
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,Inverse variance weighted,5,1.02 [0.91-1.15],0.719218561745964,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_STR,Inverse variance weighted,5,0.98 [0.87-1.1],0.721700687832356,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XII Diseases of the skin and subcutaneous tissue,L12_OTHERSKINSUBCUTIS,Inverse variance weighted,5,1.03 [0.88-1.19],0.730653906011626,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_DIVERTIC,Inverse variance weighted,5,1.01 [0.94-1.09],0.731704452457536,cis
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,Inverse variance weighted,5,1.02 [0.93-1.12],0.733524073967429,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_ABAORTANEUR,Inverse variance weighted,5,1.05 [0.8-1.37],0.745204839541638,cis
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,Inverse variance weighted,5,0.96 [0.74-1.24],0.747437817302454,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRLOW,Inverse variance weighted,5,1.06 [0.74-1.51],0.761307176077276,cis
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,Inverse variance weighted,5,0.97 [0.78-1.2],0.766064081314147,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_OTHDISSTOMDUOD,Inverse variance weighted,5,1.04 [0.8-1.36],0.769179630049628,cis
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,AB1_CANDIDIASIS,Inverse variance weighted,5,1.03 [0.83-1.3],0.771871492219834,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIV Diseases of the genitourinary system,N14_RENALTUB,Inverse variance weighted,5,1.01 [0.95-1.07],0.779747445809301,cis
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,AB1_OTHER_VIRAL,Inverse variance weighted,5,1.02 [0.91-1.14],0.780228741279686,cis
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,AB1_BACT_BIR_OTHER_INF_AGENTS,Inverse variance weighted,5,0.97 [0.78-1.21],0.780568656724202,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,BRADY_UNSPE,Inverse variance weighted,3,0.98 [0.82-1.16],0.78686785400495,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_FIBROCHIRLIV,Inverse variance weighted,5,0.96 [0.74-1.25],0.788965780065524,cis
FABP1,"Fatty acid-binding protein, liver",Chapter X Diseases of the respiratory system,J10_RESPIRATORY,Inverse variance weighted,3,0.99 [0.94-1.05],0.799195508722344,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_OTHINT,Inverse variance weighted,5,1.03 [0.83-1.26],0.809728232952438,cis
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,Inverse variance weighted,5,0.96 [0.72-1.3],0.81291066307945,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIV Diseases of the genitourinary system,N14_KIDUROTH,Inverse variance weighted,5,0.98 [0.8-1.19],0.813705651629939,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUENAS,Inverse variance weighted,5,1.04 [0.77-1.39],0.817551156299008,cis
FABP1,"Fatty acid-binding protein, liver",Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,Inverse variance weighted,5,1.01 [0.95-1.06],0.837028094017048,cis
FABP1,"Fatty acid-binding protein, liver",Chapter X Diseases of the respiratory system,J10_PLEUREFFUSION,Inverse variance weighted,5,0.98 [0.83-1.16],0.838048740523467,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,Inverse variance weighted,5,0.95 [0.57-1.58],0.840524031837696,cis
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,C_DIFFICILE_ENTEROCOLITIS,Inverse variance weighted,5,0.98 [0.8-1.2],0.851850669890218,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_AF,Inverse variance weighted,5,1.01 [0.93-1.09],0.853166394412749,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROPATHIES,Inverse variance weighted,5,1 [0.95-1.04],0.864269241656878,cis
FABP1,"Fatty acid-binding protein, liver",Chapter V Mental and behavioural disorders,ALCOHOLMENTAL,Inverse variance weighted,3,1.01 [0.87-1.18],0.866625797702746,cis
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_VIRAL_IMPL,Inverse variance weighted,3,0.98 [0.81-1.2],0.866969534397179,cis
FABP1,"Fatty acid-binding protein, liver",Chapter X Diseases of the respiratory system,J10_RESPDISOTH,Inverse variance weighted,3,1.01 [0.9-1.13],0.881711644048177,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIV Diseases of the genitourinary system,N14_RENFAILNAS,Inverse variance weighted,5,1.02 [0.81-1.27],0.886718996777398,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,Inverse variance weighted,5,1 [0.96-1.05],0.88909004188188,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_OTHER_WIDE,Inverse variance weighted,5,0.99 [0.86-1.14],0.894001929483289,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIV Diseases of the genitourinary system,N14_OBSTRUREFLUROPATH,Inverse variance weighted,5,0.99 [0.82-1.19],0.906673251717778,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_ATHSCLE,Inverse variance weighted,5,1.01 [0.85-1.2],0.907553696061869,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_RHEUVALV,Inverse variance weighted,5,0.98 [0.64-1.5],0.929841490616005,cis
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_HYPTENS,Inverse variance weighted,5,1 [0.95-1.04],0.939785395949331,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIV Diseases of the genitourinary system,N14_HYDRONEPHR,Inverse variance weighted,5,0.99 [0.78-1.26],0.946781486947277,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIV Diseases of the genitourinary system,N14_TUBULOINTNEPHRNAS,Inverse variance weighted,5,0.99 [0.75-1.31],0.948034610147746,cis
FABP1,"Fatty acid-binding protein, liver",Chapter V Mental and behavioural disorders,F5_DELIRIUM,Inverse variance weighted,5,0.99 [0.81-1.22],0.948918950948706,cis
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,Inverse variance weighted,5,1.01 [0.86-1.18],0.950283130064417,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_GALLBILPANC,Inverse variance weighted,3,1 [0.92-1.09],0.961625905758032,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOCHONDRO,Inverse variance weighted,5,1 [0.91-1.09],0.966343899072894,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIV Diseases of the genitourinary system,N14_GENITOURINARY,Inverse variance weighted,3,1 [0.95-1.05],0.974238191755634,cis
FABP1,"Fatty acid-binding protein, liver",Chapter X Diseases of the respiratory system,J10_INFLUPNEU,Inverse variance weighted,5,1 [0.94-1.06],0.978688231427826,cis
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,Inverse variance weighted,3,1 [0.79-1.28],0.979615307196245,cis
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_IRON_MET,Inverse variance weighted,5,0.99 [0.53-1.86],0.982554768866344,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_CONSTIPATION,Inverse variance weighted,5,1 [0.94-1.07],0.991376266724972,cis
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,Inverse variance weighted,5,1 [0.8-1.25],0.999582908881716,cis
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUE,Inverse variance weighted,2,1.37 [1.13-1.67],0.0014579038994486,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_MI_STRICT,Inverse variance weighted,2,0.51 [0.32-0.79],0.00307959732525438,trans
FABP1,"Fatty acid-binding protein, liver",Chapter VI Diseases of the nervous system,FALLS,Inverse variance weighted,2,0.78 [0.63-0.95],0.0125510706135124,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_ILEUS,Inverse variance weighted,2,2.05 [1.15-3.65],0.0145861699023817,trans
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,Inverse variance weighted,2,3.36 [1.19-9.48],0.0217826761523632,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,Inverse variance weighted,2,0.21 [0.06-0.81],0.0237422126039942,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROPATHIES,Inverse variance weighted,2,1.23 [1.02-1.48],0.0282394666256205,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_K_CARDIAC,Inverse variance weighted,2,0.63 [0.41-0.95],0.0288802757890584,trans
FABP1,"Fatty acid-binding protein, liver",Chapter X Diseases of the respiratory system,J10_ASTHMA_EXMORE,Inverse variance weighted,2,1.37 [1.03-1.82],0.0291169547390905,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_CARDARR,Inverse variance weighted,2,0.28 [0.09-0.9],0.0320340473536562,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_CARDMYO,Inverse variance weighted,2,0.47 [0.23-0.95],0.0342964278428574,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,Inverse variance weighted,2,8.73 [1.11-68.44],0.0392701852281671,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,Inverse variance weighted,2,0.17 [0.03-0.99],0.0482612659347752,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_AVBLOCK,Inverse variance weighted,2,0.46 [0.21-0.99],0.0482767912844009,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,GOUT_NOS,Inverse variance weighted,2,0.42 [0.18-1],0.0490034244579051,trans
FABP1,"Fatty acid-binding protein, liver",Chapter X Diseases of the respiratory system,J10_LOWCHRON,Inverse variance weighted,2,1.25 [0.99-1.57],0.0563087418032253,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_CORATHER,Inverse variance weighted,2,0.75 [0.56-1.01],0.0591757701918648,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XIV Diseases of the genitourinary system,N14_HYDRONEPHR,Inverse variance weighted,2,2.39 [0.95-6],0.0643579643677316,trans
FABP1,"Fatty acid-binding protein, liver",Chapter V Mental and behavioural disorders,F5_ALCOHOL_DEPENDENCE,Inverse variance weighted,2,0.61 [0.35-1.05],0.0746094525882858,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_ATHSCLE,Inverse variance weighted,2,0.62 [0.36-1.05],0.0756294840002042,trans
FABP1,"Fatty acid-binding protein, liver",Chapter V Mental and behavioural disorders,SMOKING_DEPEND,Inverse variance weighted,2,0.37 [0.12-1.13],0.0809026065000896,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS_OTH,Inverse variance weighted,2,1.41 [0.96-2.08],0.0815594930676869,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_CONSTIPATION,Inverse variance weighted,2,1.3 [0.96-1.75],0.0861955252425338,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XIV Diseases of the genitourinary system,N14_DIALYSIS,Inverse variance weighted,2,4.19 [0.8-21.85],0.0888888875719376,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_OTHILLHEART,Inverse variance weighted,2,0.31 [0.08-1.22],0.0937642533855352,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_IHD,Inverse variance weighted,2,0.8 [0.62-1.04],0.0961234515479618,trans
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,Inverse variance weighted,2,0.43 [0.15-1.19],0.104112597859385,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_ALCOLIV,Inverse variance weighted,2,0.44 [0.16-1.2],0.108585745717082,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XII Diseases of the skin and subcutaneous tissue,L12_OTHERSKINSUBCUTIS,Inverse variance weighted,2,1.32 [0.93-1.87],0.121961983230445,trans
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,AB1_INTESTINAL_INFECTIONS,Inverse variance weighted,2,0.8 [0.61-1.06],0.122264060327472,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_OTHENTERCOL,Inverse variance weighted,2,0.63 [0.35-1.14],0.126577364767616,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XII Diseases of the skin and subcutaneous tissue,L12_INFECT_SKIN,Inverse variance weighted,2,0.75 [0.52-1.09],0.127012426940372,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSOPATHY,Inverse variance weighted,2,1.16 [0.96-1.41],0.130802713101482,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSOPATHYOTH,Inverse variance weighted,2,1.18 [0.95-1.46],0.140460832060075,trans
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,Inverse variance weighted,2,0.36 [0.09-1.44],0.148555028979323,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_DISLIVOTH,Inverse variance weighted,2,1.8 [0.81-3.98],0.149240792118256,trans
FABP1,"Fatty acid-binding protein, liver",Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,Inverse variance weighted,2,0.76 [0.51-1.11],0.15787823781197,trans
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,AB1_VIRAL_OTHER_INTEST_INFECTIONS,Inverse variance weighted,2,0.64 [0.35-1.19],0.160924646762728,trans
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,AB1_BACT_INTEST_OTH,Inverse variance weighted,2,0.54 [0.23-1.29],0.164551937936403,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,NAFLD,Inverse variance weighted,2,2.18 [0.72-6.56],0.165245740354186,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,CHIRHEP_NAS,Inverse variance weighted,2,0.34 [0.07-1.59],0.169594613413487,trans
FABP1,"Fatty acid-binding protein, liver",Chapter VI Diseases of the nervous system,G6_HEMIPLE,Inverse variance weighted,2,0.39 [0.1-1.49],0.169765113244372,trans
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,C_DIFFICILE_ENTEROCOLITIS,Inverse variance weighted,2,0.51 [0.19-1.34],0.173860524452721,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,Inverse variance weighted,2,0.68 [0.4-1.18],0.17531323388471,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,JOINTPAIN,Inverse variance weighted,2,1.27 [0.9-1.81],0.175676807141657,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_HEARTFAIL,Inverse variance weighted,2,0.78 [0.55-1.12],0.176487056347769,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS,Inverse variance weighted,2,1.18 [0.93-1.49],0.180057368228745,trans
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACT_INOTHER,Inverse variance weighted,2,8.96 [0.35-232.06],0.186467809175859,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XIV Diseases of the genitourinary system,N14_OBSTRUREFLUROPATH,Inverse variance weighted,2,1.76 [0.75-4.11],0.193359725785007,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_OTHFUNC,Inverse variance weighted,2,1.32 [0.87-2.02],0.196185282123325,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_AF,Inverse variance weighted,2,0.71 [0.42-1.2],0.196496282403464,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_CHD,Inverse variance weighted,2,0.76 [0.5-1.16],0.206151946192099,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUEOTH,Inverse variance weighted,2,1.19 [0.91-1.57],0.207508890220211,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_INTESTOTH,Inverse variance weighted,2,1.15 [0.92-1.43],0.219525074996789,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,Inverse variance weighted,2,4.46 [0.4-49.54],0.223371729415813,trans
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_IRON_MET,Inverse variance weighted,2,5.53 [0.3-101.54],0.249338291424294,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_FIBROCHIRLIV,Inverse variance weighted,2,0.49 [0.14-1.67],0.254400506511364,trans
FABP1,"Fatty acid-binding protein, liver","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H7_CATARACTOTHER,Inverse variance weighted,2,1.28 [0.83-1.97],0.257279695425501,trans
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,Inverse variance weighted,2,0.62 [0.27-1.42],0.26022394215672,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_OTHGASTR,Inverse variance weighted,2,0.71 [0.39-1.32],0.282258814113701,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_VARICVEOES,Inverse variance weighted,2,0.17 [0.01-4.4],0.284340174671141,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XIV Diseases of the genitourinary system,N14_KIDUROTH,Inverse variance weighted,2,0.62 [0.25-1.51],0.290623985627037,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_OTHDIG,Inverse variance weighted,2,1.26 [0.82-1.92],0.292838115075161,trans
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,Inverse variance weighted,2,0.58 [0.21-1.63],0.305130615202723,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,Inverse variance weighted,2,0.85 [0.62-1.17],0.320221793474003,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Inverse variance weighted,2,0.76 [0.43-1.33],0.329357576142757,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SPONDYLOSIS,Inverse variance weighted,2,1.33 [0.74-2.39],0.334683017384851,trans
FABP1,"Fatty acid-binding protein, liver",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_PURPURA_AND3_OTHER_HAEMORRHAGIC,Inverse variance weighted,2,1.51 [0.65-3.51],0.337968802269755,trans
FABP1,"Fatty acid-binding protein, liver",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_IRONDEF_NAS,Inverse variance weighted,2,0.68 [0.31-1.5],0.342338591211592,trans
FABP1,"Fatty acid-binding protein, liver",Chapter VI Diseases of the nervous system,G6_NERPLEX,Inverse variance weighted,2,1.13 [0.87-1.47],0.346101240002237,trans
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,Inverse variance weighted,2,0.71 [0.35-1.45],0.350397675266619,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_COELIAC,Inverse variance weighted,2,1.5 [0.62-3.62],0.36313598930491,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SPONDYLOPATHY,Inverse variance weighted,2,1.2 [0.81-1.78],0.370977118266537,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUENAS,Inverse variance weighted,2,0.56 [0.14-2.23],0.411219926081951,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XIV Diseases of the genitourinary system,N14_RENFAILNAS,Inverse variance weighted,2,1.54 [0.55-4.35],0.414116393287452,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_LBBB,Inverse variance weighted,2,0.62 [0.19-2.06],0.433605303704676,trans
FABP1,"Fatty acid-binding protein, liver",Chapter X Diseases of the respiratory system,COPD_EARLY,Inverse variance weighted,2,1.29 [0.68-2.42],0.434311220276727,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_DIVERTIC,Inverse variance weighted,2,0.77 [0.41-1.48],0.437516958589856,trans
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_ACIDOSIS,Inverse variance weighted,2,0.39 [0.04-4.35],0.447402214148304,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_GOUT,Inverse variance weighted,2,0.74 [0.33-1.63],0.449038191974974,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_ARTOTH,Inverse variance weighted,2,1.48 [0.53-4.09],0.450992932253973,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_OESSTODUO,Inverse variance weighted,2,1.21 [0.72-2.05],0.468011526867818,trans
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,AB1_OTHER_SEPSIS,Inverse variance weighted,2,0.82 [0.48-1.41],0.474685502905978,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_UAP,Inverse variance weighted,2,1.2 [0.73-1.98],0.479019724279171,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_NOS,Inverse variance weighted,2,0.62 [0.16-2.43],0.488585851055884,trans
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOKALAEMIA,Inverse variance weighted,2,0.73 [0.29-1.83],0.498132412922878,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,Inverse variance weighted,2,0.92 [0.74-1.16],0.499063260348095,trans
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACTERIAL,Inverse variance weighted,2,0.87 [0.58-1.31],0.499143476967313,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_OTHDISSTOMDUOD,Inverse variance weighted,2,1.53 [0.44-5.26],0.50221423087186,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XIV Diseases of the genitourinary system,N14_URINOTH,Inverse variance weighted,2,0.91 [0.68-1.21],0.502276394494559,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XII Diseases of the skin and subcutaneous tissue,L12_DECUBITANSULCERANDPRESSURE,Inverse variance weighted,2,0.42 [0.03-5.2],0.502313101165624,trans
FABP1,"Fatty acid-binding protein, liver","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H7_CHOROIDRETINA,Inverse variance weighted,2,1.11 [0.81-1.52],0.505015404387145,trans
FABP1,"Fatty acid-binding protein, liver",Chapter X Diseases of the respiratory system,J10_INFLUPNEU,Inverse variance weighted,2,1.13 [0.78-1.63],0.515327384490916,trans
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,AB1_CANDIDIASIS,Inverse variance weighted,2,0.69 [0.22-2.16],0.526010988314407,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_PERITON,Inverse variance weighted,2,1.42 [0.48-4.25],0.52616911335101,trans
FABP1,"Fatty acid-binding protein, liver",Chapter V Mental and behavioural disorders,AUD,Inverse variance weighted,2,0.87 [0.56-1.35],0.530868595454709,trans
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,Inverse variance weighted,2,0.81 [0.41-1.58],0.539567402222502,trans
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,Inverse variance weighted,2,0.84 [0.47-1.5],0.548405449332145,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_ABAORTANEUR,Inverse variance weighted,2,0.58 [0.1-3.41],0.549359074709189,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_STR,Inverse variance weighted,2,0.83 [0.45-1.54],0.559206889269099,trans
FABP1,"Fatty acid-binding protein, liver","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_MACULOPATHY_EXMORE,Inverse variance weighted,2,0.77 [0.32-1.87],0.562246311716881,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XIV Diseases of the genitourinary system,N14_ACUTERENFAIL,Inverse variance weighted,2,0.82 [0.41-1.63],0.564324097880899,trans
FABP1,"Fatty acid-binding protein, liver",Chapter V Mental and behavioural disorders,F5_DELIRIUM,Inverse variance weighted,2,1.33 [0.5-3.49],0.565606179557377,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_HYPTENSPUL,Inverse variance weighted,2,0.26 [0-25.32],0.567621568517427,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_ENERCOLNONINF,Inverse variance weighted,2,0.8 [0.38-1.7],0.569602717373311,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_OTHER_WIDE,Inverse variance weighted,2,0.79 [0.34-1.83],0.5836108416669,trans
FABP1,"Fatty acid-binding protein, liver",Chapter X Diseases of the respiratory system,J10_EMPHYSEMA,Inverse variance weighted,2,0.72 [0.21-2.41],0.588385858937805,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,Inverse variance weighted,2,0.24 [0-51.85],0.603158600068455,trans
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,AB1_BACT_BIR_OTHER_INF_AGENTS,Inverse variance weighted,2,0.76 [0.27-2.14],0.608752096379605,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_RBBB,Inverse variance weighted,2,0.64 [0.12-3.52],0.609566933919992,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_OTHINFLIV,Inverse variance weighted,2,1.36 [0.4-4.67],0.624269213113536,trans
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,Inverse variance weighted,2,0.37 [0.01-20.14],0.624796644802234,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOCHONDRO,Inverse variance weighted,2,0.91 [0.61-1.34],0.6251253513623,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_HEPFAIL,Inverse variance weighted,2,1.81 [0.13-24.8],0.655372944683498,trans
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,AB1_STREPTSTAPHYCOCC_INOTHER,Inverse variance weighted,2,0.38 [0.01-26.69],0.656936737241257,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_RHEUMA,Inverse variance weighted,2,0.83 [0.35-1.97],0.675213735752465,trans
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,AB1_MYCOSES,Inverse variance weighted,2,0.82 [0.32-2.1],0.677396153251912,trans
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,Inverse variance weighted,2,0.95 [0.74-1.22],0.683864600449533,trans
FABP1,"Fatty acid-binding protein, liver",Chapter VI Diseases of the nervous system,G6_POLYOTHUNS,Inverse variance weighted,2,0.86 [0.42-1.76],0.684853206396498,trans
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_OBESITY,Inverse variance weighted,2,1.12 [0.63-1.97],0.705498060159135,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_OTHDISDIG,Inverse variance weighted,2,1.1 [0.66-1.85],0.713747114752724,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_HYPOTE,Inverse variance weighted,2,1.16 [0.52-2.57],0.721364633367759,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_GASTRODUOULC,Inverse variance weighted,2,1.4 [0.21-9.16],0.724609996347484,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_PAROXTAC,Inverse variance weighted,2,0.9 [0.51-1.59],0.729309795716835,trans
FABP1,"Fatty acid-binding protein, liver",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIAINCHRONICDISEASE,Inverse variance weighted,2,1.45 [0.17-12.53],0.733774341324279,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_MALABSORB,Inverse variance weighted,2,1.29 [0.29-5.78],0.73824235369636,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRLOW,Inverse variance weighted,2,0.75 [0.14-4.03],0.740325385432527,trans
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,AB1_BACTINF_NOS,Inverse variance weighted,2,0.94 [0.63-1.4],0.746255151835084,trans
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2OPTH,Inverse variance weighted,2,0.88 [0.38-2.01],0.752716593230276,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_HYPTENS,Inverse variance weighted,2,0.96 [0.74-1.24],0.75726188719854,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOPOROSIS,Inverse variance weighted,2,0.88 [0.38-2.04],0.767391080074434,trans
FABP1,"Fatty acid-binding protein, liver",Chapter V Mental and behavioural disorders,F5_DEPRESSIO,Inverse variance weighted,2,0.96 [0.73-1.27],0.772223030828659,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_LIVER,Inverse variance weighted,2,1.08 [0.65-1.8],0.773447830235432,trans
FABP1,"Fatty acid-binding protein, liver",Chapter X Diseases of the respiratory system,J10_PLEURA,Inverse variance weighted,2,1.08 [0.63-1.86],0.781026576417558,trans
FABP1,"Fatty acid-binding protein, liver",Chapter X Diseases of the respiratory system,J10_LOWERINF,Inverse variance weighted,2,0.95 [0.65-1.38],0.790651928968013,trans
FABP1,"Fatty acid-binding protein, liver",Chapter X Diseases of the respiratory system,J10_PLEUREFFUSION,Inverse variance weighted,2,0.85 [0.24-3.04],0.804194441175106,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_OTHPER,Inverse variance weighted,2,0.79 [0.13-5.02],0.804771918212071,trans
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,Inverse variance weighted,2,1.47 [0.06-35.91],0.812453342614435,trans
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,Inverse variance weighted,2,1.09 [0.52-2.3],0.817079342852051,trans
FABP1,"Fatty acid-binding protein, liver",Chapter X Diseases of the respiratory system,J10_ACUTELOWERNAS,Inverse variance weighted,2,1.09 [0.5-2.38],0.822931142677392,trans
FABP1,"Fatty acid-binding protein, liver",Chapter VI Diseases of the nervous system,G6_CPETAL,Inverse variance weighted,2,1.16 [0.31-4.32],0.824286759543414,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_ANGINA,Inverse variance weighted,2,0.97 [0.69-1.35],0.845796096581308,trans
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,Inverse variance weighted,2,1.04 [0.68-1.61],0.84817078079489,trans
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,Inverse variance weighted,2,0.96 [0.58-1.57],0.858652831837158,trans
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,AB1_GASTROENTERITIS_NOS,Inverse variance weighted,2,0.95 [0.54-1.67],0.859863401519072,trans
FABP1,"Fatty acid-binding protein, liver",Chapter V Mental and behavioural disorders,F5_DEPRESSION_DYSTHYMIA,Inverse variance weighted,2,0.98 [0.75-1.28],0.865178293317633,trans
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,Inverse variance weighted,2,0.98 [0.76-1.26],0.87130118125564,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XIV Diseases of the genitourinary system,N14_CHRONEPHROPATH,Inverse variance weighted,2,0.88 [0.18-4.28],0.875279575333339,trans
FABP1,"Fatty acid-binding protein, liver",Chapter I Certain infectious and parasitic diseases,AB1_OTHER_VIRAL,Inverse variance weighted,2,1.06 [0.51-2.2],0.876222241912755,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XIV Diseases of the genitourinary system,N14_TUBULOINTNEPHRNAS,Inverse variance weighted,2,0.92 [0.29-2.88],0.880047606907662,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_RHEUVALV,Inverse variance weighted,2,1.16 [0.16-8.44],0.881681811258304,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_OTHINT,Inverse variance weighted,2,0.93 [0.36-2.39],0.881880704409266,trans
FABP1,"Fatty acid-binding protein, liver",Chapter X Diseases of the respiratory system,COPD_LATER,Inverse variance weighted,2,1.04 [0.61-1.79],0.883298373901527,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_OTHOTH,Inverse variance weighted,2,0.8 [0.04-15.46],0.885527710386647,trans
FABP1,"Fatty acid-binding protein, liver",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_THROMBOCYTOPENIANAS,Inverse variance weighted,2,0.92 [0.27-3.08],0.886832005999985,trans
FABP1,"Fatty acid-binding protein, liver",Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,Inverse variance weighted,2,0.97 [0.62-1.51],0.89009123927559,trans
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPEROSMHNAT,Inverse variance weighted,2,1.18 [0.06-21.56],0.910141307162136,trans
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,Inverse variance weighted,2,1.07 [0.32-3.6],0.917513042797545,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XIV Diseases of the genitourinary system,N14_RENALTUB,Inverse variance weighted,2,0.99 [0.74-1.31],0.917714828194804,trans
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,Inverse variance weighted,2,1.06 [0.35-3.22],0.924381828128756,trans
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,Inverse variance weighted,2,0.78 [0-156.86],0.928224089267278,trans
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,Inverse variance weighted,2,1.01 [0.74-1.38],0.928879082788844,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XII Diseases of the skin and subcutaneous tissue,L12_ULCERLOWLIMB,Inverse variance weighted,2,1.03 [0.44-2.44],0.944154072269253,trans
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,Inverse variance weighted,2,0.98 [0.6-1.61],0.944552590849428,trans
FABP1,"Fatty acid-binding protein, liver",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIANAS,Inverse variance weighted,2,0.98 [0.62-1.56],0.94815661550986,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,Inverse variance weighted,2,1.01 [0.73-1.39],0.957640400189542,trans
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,Inverse variance weighted,2,1.03 [0.33-3.23],0.95810506372279,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,Inverse variance weighted,2,1.04 [0.2-5.42],0.966966467693035,trans
FABP1,"Fatty acid-binding protein, liver","Chapter IV Endocrine, nutritional and metabolic diseases",E4_OBESITYNAS,Inverse variance weighted,2,0.99 [0.5-1.96],0.975787702054324,trans
FABP1,"Fatty acid-binding protein, liver",Chapter IX Diseases of the circulatory system,I9_SEQULAE,Inverse variance weighted,2,1.02 [0.32-3.23],0.975815369093672,trans
FABP1,"Fatty acid-binding protein, liver",Chapter X Diseases of the respiratory system,J10_PULMOEDEMA,Inverse variance weighted,2,1.04 [0.02-66.54],0.986531555000014,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XII Diseases of the skin and subcutaneous tissue,L12_CELLULITIS,Inverse variance weighted,2,1 [0.53-1.92],0.99198313705327,trans
FABP1,"Fatty acid-binding protein, liver",Chapter XI Diseases of the digestive system,K11_PERITONITIS,Inverse variance weighted,2,1.01 [0.18-5.79],0.993366754045851,trans
